Medtronic Inc. received FDA clearance of the Reveal DX Insertable Cardiac Monitor (ICM) designed to help physicians identify the cause of unexplained fainting or abnormal heart rhythms, including ventricular tachyarrhythmias (VT), fast ventricular tachyarrhythmias (FVT), bradyarrhythmias and asystole.
February 5, 2008 - Premera Blue Cross has revised its Corporate Medical Policy to make Microvolt T-Wave Alternans ...
The Sentinel by Spacelabs reportedly integrates an entire range of noninvasive diagnostic cardiology solutions including ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
February 5, 2008 - The Medical Imaging & Technology Alliance (MITA), a division of NEMA, said today that the budget ...
A new 320-slice computed tomography (CT) system, the AquilionONE by Toshiba America Medical Systems, delivers dynamic ...
Delivering vivid and insightful CT images of the coronary vessels directly into the cardiac catheterization laboratories (cath labs) has proven very effective by helping save staff from re-acquiring images of the heart and boosting patient throughput. But CT images are only part of the bigger picture.
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
The HeartStation ECG management system automates the processing and storage of electrocardiograms to reportedly improve ...
February 5, 2008 - The FAMILION test for Long QT Syndrome (LQTS) has met the Blue Cross and Blue Shield Association ...
CardioDynamics recently received market clearance from the FDA for its BioZ Impedance Cardiography (ICG) clinical ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
February 5, 2008 – CV Therapeutics Inc. and Medlogics Device Corp. entered into an agreement under which Medlogics has ...
Fluke Biomedical's product line of defibrillator and pacemaker analyzer technologies includes the Impulse 6000D ...
February 4, 2008 - The Centers for Medicare & Medicaid Services (CMS) announced that after completing a review of its 1986 national non-coverage policy for artificial hearts, its preliminary decision is to provide reimbursement for patients who receive the CardioWest temporary Total Artificial Heart (TAH-t) as part of FDA studies that meet CMS specifications.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
February 4, 2008 - InSite One Inc.
February 4, 2008 – Fluke Biomedical unveiled today new defibrillator and pacemaker analyzer technologies, the Impulse 6000D Defibrillator Analyzer and the Impulse 7000DP Defibrillator/Pacer Analyzer, which are designed to be rugged, portable test instrumentation for biomedical technical professionals to ensure proper operation and ultimate performance of critical life-support cardiac resuscitati
February 1, 2008 - Medtronic Inc. has received approval from the FDA for the Endeavor Zotarolimus-Eluting Coronary Stent ...
February 04, 2008
